CDC provides laboratory training in single-well Limiting Antigen Avidity EIA

In January 2012, the Centers for Disease Control and Prevention (CDC) provided training to laboratory operators on the single-well HIV-1 Limiting Antigen (LAg) Avidity Enzyme Immunoassay (EIA). The Blood Systems Research Institute (BSRI), in San Francisco, hosted the training over two days - the first day dedicated to laboratory safety training, and second to the use of the LAg Avidity EIA kits.